Pages that link to "Q43036577"

The following pages link to Quantitation of hepatitis C virus RNA by third generation branched DNA-based signal amplification assay (Q43036577):

Displaying 22 items.

• Nucleic Acid-based approaches for detection of viral hepatitis (Q26866468) (← links)
• Comparison of qualitative (COBAS AMPLICOR HCV 2.0 versus VERSANT HCV RNA) and quantitative (COBAS AMPLICOR HCV monitor 2.0 versus VERSANT HCV RNA 3.0) assays for hepatitis C virus (HCV) RNA detection and quantification: impact on diagnosis and treat (Q27469977) (← links)
• Comparison of Conventional PCR with Real-Time PCR and Branched DNA-Based Assays for Hepatitis C Virus RNA Quantification and Clinical Significance for Genotypes 1 to 5 (Q27473038) (← links)
• Multicenter Evaluation of the New Abbott RealTime Assays for Quantitative Detection of Human Immunodeficiency Virus Type 1 and Hepatitis C Virus RNA (Q27480924) (← links)
• Comparison of the Abbott 7000 and Bayer 340 Systems for Measurement of Hepatitis C Virus Load (Q27481437) (← links)
• Differences between Two Real-Time PCR-Based Hepatitis C Virus (HCV) Assays (RealTime HCV and Cobas AmpliPrep/Cobas TaqMan) and One Signal Amplification Assay (Versant HCV RNA 3.0) for RNA Detection and Quantification (Q27487396) (← links)
• Analytical Performance Characteristics and Clinical Utility of a Novel Assay for Total Hepatitis C Virus Core Antigen Quantification (Q27491329) (← links)
• Variable ratio of hepatitis C virus RNA to viral core antigen in patient sera (Q33712801) (← links)
• Cyclosporine versus tacrolimus in patients with HCV infection after liver transplantation: effects on virus replication and recurrent hepatitis (Q33788431) (← links)
• Simultaneous runs of the Bayer VERSANT HIV-1 version 3.0 and HCV bDNA version 3.0 quantitative assays on the system 340 platform provide reliable quantitation and improved work flow. (Q35716193) (← links)
• New developments in the diagnosis of bloodstream infections (Q35965048) (← links)
• Multicenter evaluation of the performance characteristics of the bayer VERSANT HCV RNA 3.0 assay (bDNA) (Q36240147) (← links)
• Current therapy for hepatitis C. (Q36263113) (← links)
• Detection of infections with hepatitis B virus, hepatitis C virus, and human immunodeficiency virus by analyses of dried blood spots--performance characteristics of the ARCHITECT system and two commercial assays for nucleic acid amplification (Q36689718) (← links)
• Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes (Q40226559) (← links)
• Second-generation Cobas AmpliPrep/Cobas TaqMan HCV quantitative test for viral load monitoring: a novel dual-probe assay design (Q41913531) (← links)
• Development of a TaqMan assay for the six major genotypes of hepatitis C virus: comparison with commercial assays (Q42644492) (← links)
• Long-term follow-up after successful interferon therapy of acute hepatitis C. (Q42986131) (← links)
• Haplotype-tagging RANTES gene variants influence response to antiviral therapy in chronic hepatitis C. (Q42987580) (← links)
• Early viral load and recipient interleukin-28B rs12979860 genotype are predictors of the progression of hepatitis C after liver transplantation (Q43716197) (← links)
• Hepatitis A, B, and C (Q79411058) (← links)
• Envelope-Specific IgG3 and IgG1 Responses Are Associated with Clearance of Acute Hepatitis C Virus Infection (Q92633061) (← links)